A case of triple infection including strongyloides stercoralis in a microscopic polyangiitis patient

De-Han Cai1, Jun Wang2, Xiao-Lin Fang2

  • 1Nephrology Department in Jiangxi Provincial People's Hospital Affiliated to Nanchang University, Nanchang, 330006, Jiangxi, China.

Insights

Microscopic polyangiitis patients on immunosuppressants can develop strongyloidiasis and nocardia infections. Consider strongyloidiasis in immunocompromised individuals with systemic symptoms, even without eosinophilia, and investigate mixed infections thoroughly.

Area of Science:

  • Infectious Diseases
  • Immunology
  • Rheumatology

Background:

  • Microscopic polyangiitis (MPA) is an autoimmune disease often treated with corticosteroids and immunosuppressants.
  • Immunosuppressive therapy can increase the risk of opportunistic infections in patients with autoimmune conditions.

Observation:

  • A patient with microscopic polyangiitis developed severe infections, including strongyloidiasis, Nocardia, and Citrobacter freundii, following immunosuppressive treatment.
  • The patient presented with diverse systemic symptoms affecting digestive and respiratory systems.

Findings:

  • Strongyloidiasis should be considered in immunocompromised individuals from endemic areas presenting with gastrointestinal or respiratory symptoms, even in the absence of eosinophilia.
  • Mixed infections, such as those involving Nocardia, are common in this patient population and require diligent diagnostic efforts.

Implications:

  • Early and comprehensive diagnostic workup, employing multiple methods, is crucial for identifying opportunistic infections in immunosuppressed patients.
  • Prompt diagnosis and treatment of these infections can improve outcomes for patients with microscopic polyangiitis and other autoimmune diseases.

Related Concept Videos

Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
195
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
538
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
52
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
424